Microbiological Principle
The foundation of effective treatment is the precise identification of the causative agent and determination of its antimicrobial susceptibility profile.
- Ideal Scenario (Pathogen-Directed Approach): The physician identifies the exact microbial species and reviews its antibiogram. A narrow-spectrum drug is then prescribed to target the specific pathogen precisely.
- Empirical Approach: If the causative agent is unknown, treatment starts with broad-spectrum agents to reliably cover the most likely culprits of the infection.
After 2–3 days, when bacteriological culture results become available, de-escalation is performed—adjusting the regimen to targeted therapy. Treatment should be initiated as early as possible: early in the disease course, the microbial load is lower, and drugs are much more effective against actively dividing cells.
Pharmacological Principle
This principle requires accounting for the pharmacokinetics and pharmacodynamics of the drug. The primary goal is to successfully deliver the active substance directly to the site of inflammation.
- Regimen and Dosing: A tissue concentration must be achieved that ensures a reliable bacteriostatic (growth arrest) or bactericidal (killing) effect. The dosage is selected based on drug distribution within the body and dosing frequency.
- Duration: The course must last exactly as long as required for complete eradication of the microorganism. Relying solely on the resolution of symptoms is insufficient.
- Routes of Administration: The clinician must account for physiological barriers. For example, oral administration may be ineffective in certain infections due to poor absorption, whereas for meningitis, it is crucial to select agents capable of crossing the blood-brain barrier.
Clinical Principle
Antibiotic selection is inextricably linked to the patient's individual characteristics. Treatment must be both effective and safe.
Factors such as age, sex, pregnancy status, and immune function must be evaluated upon prescription. It is critically important to consider comorbidities and excretory organ function (liver and kidneys) to avoid systemic toxicity.
Tactics for Severe Infections: If the patient's condition is life-threatening, timeliness and maximum spectrum coverage take precedence. In such situations, combinations of 2–3 drugs are utilized, adhering to strict combination rules:
- Efficacy: Drugs must act synergistically without mutually suppressing antibacterial activity (antagonism).
- Safety: Combinations with additive toxic effects must be strictly avoided.
Epidemiological and Pharmaceutical Approaches
Successful therapy requires evaluating both global and local contexts.
- Epidemiology: The physician must be aware of local resistance patterns—which strains are circulating in a specific region, hospital, or even a specific ward. It is vital to remember that antibiotic resistance is a reversible process. Bacteria can lose acquired resistance, reverting to their wild-type susceptibility.
- Pharmaceuticals: Special attention is paid to storage conditions and expiration dates of antimicrobial agents. Violating these rules leads not only to loss of therapeutic efficacy, but chemical degradation of the active substance can also render the drug toxic. Additionally, economic aspects and the cost of the course for the patient or clinic should be considered when choosing a therapy regimen.